QbD Podcast: Regulatory and Scientific Possibilities and Challenges

Gert Ragnarsson, Director of the Swedish Medical Projects Agency, discusses the biggest milestones in QbD over the last decade, including:

• The establishment of harmonized guidelines
• The Formation of the EMA
• The recent document published by the FDA, which is a significant step in dealing with advanced formulations

Ragnarsson also looks to the future growth of generics and the effects QbD and PAT will have on that market.

This is a free Pharma IQ podcast and requires registration.

 

More News:

All news »

What are your comments?

You cannot post comments until you have logged in. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments